Source link : https://www.newshealth.biz/health-news/lilly-novo-nordisk-battle-for-weight-loss-market-lands-at-the-pharmacy-shelf/
LONDON/NEW YORK (Reuters) – As Eli Lilly’s weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk’s Wegovy, some doctors say their guiding principle for writing prescriptions is simple: which drug can my patients actually get at the pharmacy? Lilly has quickly built a roughly 40% market share in the U.S. since it launched […]
Author : News Health
Publish date : 2024-08-05 10:06:33
Copyright for syndicated content belongs to the linked Source.